< Back to previous page
Researcher
Steven Simoens
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today
Projects
1 - 10 of 22
- How to create sustainable market access to advanced therapies?From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Health Economic Evaluations of Preventive Policies in Flanders (HELPPFL)From22 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Exploring the market access of advanced therapy medicinal products (ATMPs)From17 Oct 2022 → 9 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Exploring the market environment of biologics including biosimilar medicinesFrom20 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Framework for value driven market access of gene therapyFrom1 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unlocking Biosimilar Benefits: An Exploration of Barriers to Biosimilar Adoption, Value Assessment and Market SustainabilityFrom16 Oct 2019 → 13 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- A Belgian policy framework for best-value biological medicinesFrom3 Sep 2019 → 18 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Framework for value driven market access of gene therapyFrom1 Sep 2019 → 23 Oct 2020Funding: FWO Strategic Basic Research Grant
Publications
371 - 380 of 428
- Economic aspects of diagnosis and treatment of endometriosis(2010)
Authors: Steven Simoens, Thomas D'Hooghe
Pages: 131 - 144 - Exploring the impact of medication information for psychiatric patients at hospital discharge(2009)
Authors: Siska Desplenter, Steven Simoens, Gert Laekeman
Number of pages: 332 - Orphan diseases and orphan medicines: A Belgian and European study(2009)
Authors: Steven Simoens
Pages: 109 - 115 - Medication information for Flemish inpatients with major depression: evaluation and construct validity of the Consumer Information Rating Form(2009)
Authors: Siska Desplenter, Gert Laekeman, Koen Demyttenaere, Steven Simoens
Pages: 645 - 655 - Hospital pharmacists versus hospital administrators: a struggle for clinical pharmacy services(2009)
Authors: Thomas De Rijdt, Ludo Willems, Steven Simoens
Pages: 497 - 498 - [Orphan diseases and orphan medicines: a Belgian and European study].(2009)
Authors: Steven Simoens
Pages: 131 - 137 - Analysis of drug authentication at the point of dispensing in Belgian and Greek community pharmacies(2009)
Authors: Steven Simoens
Pages: 1701 - 1706 - Developing competitive and sustainable Polish generic medicines market(2009)
Authors: Steven Simoens
Pages: 440 - 448 - Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines(2009)
Authors: Steven Simoens
Pages: 2447 - 57 - Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis(2009)
Authors: Steven Simoens, Annette Schuermans
Pages: 1853 - 1859